Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy

Journal of Clinical Pathology

Volumn 56, Issue 7, 2003, Pages 555-557

  Sebire, N J ^a   Haselden, S ^a   Malone, M ^a   Davies, E G ^a   Ramsay, A D ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CASE REPORT; EPSTEIN BARR VIRUS; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; IN SITU HYBRIDIZATION; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISORDERS; MALE; SKIN DISEASES; WISKOTT-ALDRICH SYNDROME;

EID: 0038006199     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.7.555     Document Type: Article

References (11)

1. Elenitoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1997;14:35-47.
2. Dodd GD, 3rd, Ledesma-Medina J, Baron RL, et al. Posttransplant lymphoproliferative disorder: intrathoracic manifestations. Radiology 1992;184:65-9.
3. Simon HU, Higgins EA, Demetriou M, et al. Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS). Clin Exp Immunol 1993;91:43-9.
4. Iwatsuki K, Xu Z, Ohtsuka M, et al. Cutaneous lymphoproliferative disorders associated with Epstein-Barr virus infection: a clinical overview. J Dermatol Sci 2000;22:181-95.
5. Beaty MW, Toro J, Sorbara L, et al. Cutaneous lymphomatoid granulomatosis - correlation of clinical and biological features. Am J Surg Pathol 2001;25:1111-20.
6. El Mansouri S, Martin A, Mercadier A, et al. High expression of MDM2 protein and low rate of p21 (WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced lymphoproliferation. J Histochem Cytochem 1999;47:1315-22.
7. Rincon J, Prieto J, Patarroyo M. Expression of integrins and other adhesion molecules in Epstein-Barr virus-transformed B lymphoblastoid cells and Burkitt's lymphoma cells. Int J Cancer 1992;51:452-8.
8. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001;97:1598-603.
9. Milpied N, Vasseur B, Garnier JL, et al. Humanized anti-Cd20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000;11:113S1-16S1.
10. Poul T, Radny P, Krober SM, et al. Intralesional rituximab for cutaneous B-cell lymphoma. Br J Dermatol 2001;144:1239-43.
11. Selenko N, Majdic O, Draxler S, et al. CD20 antibody (C2B8)-induced apoptosis of lymphoma cells promotes phagocytosis by dendritic cells and cross-priming of CD8+ cytotoxic cells. Leukemia 2001;15:1619-26.